It was also found that in Trop2 and seven other genes, encoding barrier molecules are highly expressed in a subset of metastatic melanomas and ovarian carcinomas, and their expression is associated with a lack of immune gene signatures and worse prognosis [120]. The gene discussed is TACSTD2; the disease is ovarian carcinoma.